Načítá se...
Cone Specific Promoter for Use in Gene Therapy of Retinal Degenerative Diseases
Achromatopsia (ACHM) is caused by a progressive loss of cone photoreceptors leading to color blindness and poor visual acuity. Animal studies and human clinical trials have shown that gene replacement therapy with adeno-associate virus (AAV) is a viable treatment option for this disease. Although th...
Uloženo v:
| Vydáno v: | Adv Exp Med Biol |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4450355/ https://ncbi.nlm.nih.gov/pubmed/24664760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-4614-3209-8_87 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|